Publication: An efficient separation and method development for the quantifying of two basic impurities of Nicergoline by reversed-phase high performance liquid chromatography using ion-pairing counter ions
| dc.contributor.authors | Yalcin, Guler; Yuktas, F. Nuray | |
| dc.date.accessioned | 2022-03-12T17:19:11Z | |
| dc.date.accessioned | 2026-01-11T08:01:47Z | |
| dc.date.available | 2022-03-12T17:19:11Z | |
| dc.date.issued | 2006 | |
| dc.description.abstract | A quantification method was developed for the two basic impurities, one of which is also a metabolite, of Nicergoline (NIC), by using reversed-phase high performance liquid chromatography (RP-HPLC) and diode array detector (DAD). One of these compounds, 10-methoxy-6-methylergoline-8 beta-methanol-5-bromo-3-pyridinecarboxylate (1-DN) is the metabolite as well as the impurity whereas, the other 10-methoxy-1,6-dimethylergoline-8 beta-methanol-5-chloro-3-pyridinecarboxylate (5-CN) is only an impurity. The chromatographic column was Phenomenex, Luna, 5 mu m, C 18 (2), 250 mm x 4.6 mm. Mobile phase was 0.1 M ammonium acetate (NH4Ac) solution containing 4 mM 1-octanesulfonicacid sodium salt (OSASS) and 6 mM tetrabutylammonium hydrogen sulphate (TBAHS) (pH: 5.9)/acetonitrile (ACN) (62:38) for 1-DN and (64:36) for 5-CN. Flow rate was 1.0 mL min(-1). The diode array detector was operated at 285 nm, band width: 4 nm. Linearity was obtained in the concentration range of 0.032 x 10(-5) to 3.828 x 10(-5) M, y = 116.88x + 0.2773 (r(2) = 0.99989); the limit of detection (LOD) and limit of quantification (LOQ) were determined as 0.012 x 10(-5) and 0.041 x 10(-5) M for 1-DN, respectively. Linearity was obtained in the concentration range of 0.034 x 10(-5) to 4.092 x 10(-5) M, y = 104.24x + 0.7486 (r(2) = 0.99996); (LOD) and (LOQ) were determined as 0.014 x 10(-5) and 0.046 x 10(-5) M for 5-CN, respectively. The recovery was 100.65% for 1-DN and 100.32% for 5-CN. The amount of 1-DN in 30 mg NIC was found as 209.65 mu g (0.70%) and the amount of 5-CN in 30 mg NIC was found as 27.62 mu g (0.09%). (c) 2006 Elsevier B.V. All rights reserved. | |
| dc.identifier.doi | 10.1016/j.jpba.2006.04.032 | |
| dc.identifier.issn | 0731-7085 | |
| dc.identifier.pubmed | 16766155 | |
| dc.identifier.uri | https://hdl.handle.net/11424/228071 | |
| dc.identifier.wos | WOS:000241125900005 | |
| dc.language.iso | eng | |
| dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | |
| dc.relation.ispartof | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Nicergoline | |
| dc.subject | basic impurities | |
| dc.subject | quantification | |
| dc.subject | ion pairing counter ions | |
| dc.subject | reversed-phase HPLC | |
| dc.subject | POLYBUTADIENE-COATED ZIRCONIA | |
| dc.subject | SILANE BONDED SILICA | |
| dc.subject | IONIZATION MASS-SPECTROMETRY | |
| dc.subject | STATIONARY PHASES | |
| dc.subject | RETENTION MECHANISM | |
| dc.subject | DRUGS | |
| dc.subject | AMINES | |
| dc.subject | PHARMACEUTICALS | |
| dc.subject | METABOLITES | |
| dc.subject | SUBSTANCES | |
| dc.title | An efficient separation and method development for the quantifying of two basic impurities of Nicergoline by reversed-phase high performance liquid chromatography using ion-pairing counter ions | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 440 | |
| oaire.citation.issue | 4 | |
| oaire.citation.startPage | 434 | |
| oaire.citation.title | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | |
| oaire.citation.volume | 42 |
